Impact of Two Iron Formulations on Iron Biomarkers and Quality of Life
Part of paid clinical trials in Carlsbad, California.
- Sponsor
- Qualia Life Sciences
- Study ID
- NCT07156526
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Iron Deficiencies
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Qualia Iron Version A — DIETARY_SUPPLEMENTQualia Iron Version A manufactured by Qualia Life Sciences
- Qualia Iron Version B — DIETARY_SUPPLEMENTQualia Iron Version B manufactured by Qualia Life Sciences
- Placebo — DIETARY_SUPPLEMENTRice powder
Study Details
This randomized, double-blind parallel pilot study will evaluate the safety and efficacy of two Qualia Iron formulations versus placebo in approximately 40 healthy adults (aged 18+) over a 56-day period. Approximately 40 participants will be randomized to three study arms: Qualia Iron Version 1, 2, (n=15 each) or a Placebo (n=10). Each participant will take one or two capsules once daily in the morning, with or without food. The supplementation regimen is a 5 days on, 2 days off protocol, and goes for 56 days (8 weeks). The primary outcomes of this study are to assess between-group changes in iron status biomarkers. Secondary outcomes include within-group changes in iron status biomarkers, safety and tolerability as measured by a custom Safety and Tolerability survey, and RAND SF-36 quality of life scores.
Key Dates
- Start date
- Sep 10, 2025
- Status verified
- Aug 2025
- Primary completion
- Nov 15, 2025
- Completion
- Nov 15, 2025
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Active Comparator: Qualia Iron Version AQualia Iron version A manufactured by Qualia Life Sciences
- Active Comparator: Qualia Iron Version BQualia Iron version B manufactured by Qualia Life Sciences
- Placebo Comparator: PlaceboRice powder
Primary Outcome Measure
Changes in iron status biomarkers [ Time Frame: From 0-4 weeks, 4-8 weeks, and 0-8 weeks ]
Central Contacts
- William Scuba855-281-2328
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Qualia Life Sciences | Carlsbad | California | 92011 |
Find similar trials in Carlsbad, CA
Related Studies
- Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart FailurePHASE3 · Recruiting · Pharmacosmos A/S · Pasadena, California
- Kids With Iron Deficiency and ScoliosisRecruiting · Columbia University · New York, New York
- Influences of Long-acting Reversible Contraceptives on Iron Status and Physiological Responses to Extreme Environments in WomenRecruiting · United States Army Research Institute of Environmental Medicine · Natick, Massachusetts
- A Pilot Study to Evaluate the Ability of Lactoferrin to Modulate Iron Homeostasis and Exercise Performance in Exercising FemalesRecruiting · Lindenwood University · Saint Charles, Missouri